BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10423048)

  • 1. Assessment of dyspnea in advanced cancer patients.
    Mancini I; Body JJ
    Support Care Cancer; 1999 Jul; 7(4):229-32. PubMed ID: 10423048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1185-9. PubMed ID: 9769280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD.
    de Torres JP; Pinto-Plata V; Ingenito E; Bagley P; Gray A; Berger R; Celli B
    Chest; 2002 Apr; 121(4):1092-8. PubMed ID: 11948037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of dyspnea in quality of life of the patient with chronic obstructive pulmonary disease].
    Elías Hernández MT; Ortega Ruiz F; Sánchez Riera H; Otero Candelera R; Sánchez Gil R; Montemayor Rubio T
    Arch Bronconeumol; 1999 Jun; 35(6):261-6. PubMed ID: 10410205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of dyspnea in sarcoidosis using the Baseline Dyspnea Index (BDI) and the Transition Dyspnea Index (TDI).
    Obi ON; Judson MA; Birring SS; Maier LA; Wells AU; Lower EE; Baughman RP
    Respir Med; 2022 Jan; 191():106436. PubMed ID: 33992496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyspnoea: a study of measurement instruments for the assessment of dyspnoea and their application for patients with advanced cancer.
    van der Molen B
    J Adv Nurs; 1995 Nov; 22(5):948-56. PubMed ID: 8568070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of dyspnea in advanced cancer patients.
    Ripamonti C
    Support Care Cancer; 1999 Jul; 7(4):233-43. PubMed ID: 10423049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyspnea: assessment and treatment.
    Farncombe M
    Support Care Cancer; 1997 Mar; 5(2):94-9. PubMed ID: 9069607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD.
    Javadzadeh S; Chowienczyk S; Booth S; Farquhar M
    BMJ Support Palliat Care; 2016 Mar; 6(1):105-8. PubMed ID: 26685116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weighing up the evidence -- a systematic review of measures used for the sensation of breathlessness in obesity.
    Gerlach Y; Williams MT; Coates AM
    Int J Obes (Lond); 2013 Mar; 37(3):341-9. PubMed ID: 22531088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes.
    Mahler DA; Waterman LA; Ward J; McCusker C; ZuWallack R; Baird JC
    Chest; 2007 Oct; 132(4):1283-90. PubMed ID: 17646223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized breathlessness interventions may improve outcomes in patients with advanced COPD.
    Qian MYY; Politis J; Thompson M; Wong D; Le B; Irving L; Smallwood N
    Respirology; 2018 Dec; 23(12):1146-1151. PubMed ID: 29763515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation.
    Aaron SD; Vandemheen KL; Clinch JJ; Ahuja J; Brison RJ; Dickinson G; Hébert PC
    Chest; 2002 Mar; 121(3):688-96. PubMed ID: 11888946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The evaluation of dyspnea and quality of life in COPD].
    Demir G; Akkoca O; Doğan R; Saryal S; Karabiyikoğlu G
    Tuberk Toraks; 2003; 51(4):365-72. PubMed ID: 15143383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ways to quantify dyspnea severity. Part I. Baseline Dyspnea Index (BDI), Transition Dyspnea Index (TDI)].
    Nemeş R; Bumbăcea D
    Pneumologia; 2006; 55(2):58-63. PubMed ID: 17069203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyspnea in COPD: beyond the modified Medical Research Council scale.
    Camargo LA; Pereira CA
    J Bras Pneumol; 2010; 36(5):571-8. PubMed ID: 21085822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease.
    Schlecht NF; Schwartzman K; Bourbeau J
    Chron Respir Dis; 2005; 2(4):183-91. PubMed ID: 16541601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis of four randomized clinical trials to confirm the reliability and responsiveness of the Shortness of Breath with Daily Activities (SOBDA) questionnaire in chronic obstructive pulmonary disease.
    Tabberer M; Brooks J; Wilcox T
    Health Qual Life Outcomes; 2015 Oct; 13():177. PubMed ID: 26520062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison of several measurement scales for assessing dyspnea in their daily activities in patients with chronic obstructive lung disease].
    Ruiz de Oña Lacasta JM; Puente Maestu L; Rodríguez Hermosa JL; Tatay Martí E; Cubillo Marcos JM
    Arch Bronconeumol; 2000 Jan; 36(1):25-8. PubMed ID: 10726181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.